Resultados de la búsqueda 51-60 of 9185 for Drug-resistant TB
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
ABBV-383 is an investigational drug being ... resistant chronic lymphocytic leukemia. Patients ... Patients randomized to B+R will receive 6 cycles of treatment ...
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...
... resistant to platinum drugs. Effect of Agent Orange Exposure on Endocrine Tumor Aggressiveness. Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix ...
The primary outcome of this study is to evaluate the immunogenicity of the Covid-19 vaccine in patients with IBD. A Study to Evaluate the QuantiFERON-TB Gold- ...
The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...
Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...
The purpose of this study is to evaluate nurse-based care coordination compared to usual care on 30-day risk-adjusted readmission rates among high risk patients ...
... treatment in patients with treatment ... resistant chronic lymphocytic leukemia. Patients ... Patients randomized to B+R will receive 6 cycles of treatment ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?